The Phoenix Mills Ltd. (PDF)
Top Losers
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
SIP Calculator
Retirement Planning Calculator
Adani Ports and SEZ
Nath Bio-Genes Share Price
Nath Bio-Genes (INR)187.090.3 (0.2%) 
Exchange ScripsBSE537291NSENATHBIOGENISININE448G01010
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Nath Bio-Genes Performance
Market performance
Open price188.4
High195
Volumes18902
Prev Close187.09
Low186.21
Closing date2024-12-27
Historical performance
1 Year High264.31
3 Year High288.50
5 Year High473.95
1 Year Low167.15
3 Year Low128.85
5 Year Low127.30
Nath Bio-Genes Fundamentals
Company Valuation
Market Cap (₹Cr)
354
Face Value (₹)
10
P/E Ratio
8.97
Dividend Yield
0.11 %
Nath Bio-Genes Investment Returns
1 Year
-8.5%
3 Years
-24.6%
5 Years
-46.7%
10 Years
48.9%
Nath Bio-Genes Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 187.49 | Bearish |
| 10-DMA | 191.34 | Bearish |
| 20-DMA | 195.32 | Bearish |
| 50-DMA | 190.89 | Bearish |
| 100-DMA | 205.06 | Bearish |
| 200-DMA | 205.26 | Bearish |
Shareholding Pattern
| Field | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 | Sep-2023 |
|---|---|---|---|---|---|
| Promoters | 16 | 16 | 16 | 17 | 17 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 16 | 16 | 16 | 17 | 17 |
| Public Investors | 35407 | 35818 | 35116 | 34246 | 34348 |
| Government | --- | --- | --- | --- | --- |
Nath Bio-Genes Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|
| Other Income | 6 | 6 | 19 |
| Operating Profit | 506 | 495 | 391 |
| Interest | 92 | 104 | 106 |
| Depreciation | 33 | 30 | 31 |
| Profit Before Tax | 416 | 362 | -634 |
| Consolidated Net Profit | 396 | 350 | -674 |
| Adjusted EPS | 21 | 18 | -35 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|
| Share Capital | 190 | 190 | 190 |
| Total Reserves | 5909 | 5542 | 5229 |
| Minority Interest | --- | --- | --- |
| Total Non-Current Liabilities | 79 | 32 | 33 |
| Total Liabilities | 8802 | 7928 | 7395 |
| Capital Work in Progress | --- | --- | --- |
| Total Assets | 8802 | 7928 | 7395 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|
| Cash Flow from Operating Activities | 746 | 384 | 170 |
| Cash Flow from Investing Activities | -274 | -29 | -199 |
| Cash Flow from Financing Activitie | -78 | -17 | -222 |
| Net Cash Inflow / Outflow | 394 | 338 | -250 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 8.97.
- 3Y Stock Price CAGR of the stock is -11.1.
- The stock has a beta of 1.1.
- In the last financial year, the company had an EBITDA of ₹506 Million.
- The company generated revenue of ₹3326 Million in the previous financial year.
Nath Bio-Genes
187.090.3 (0.2%)
Investment Amount: ₹ 21220
Current Value: ₹ 18709
Performance: -11.8%
P/L: ₹ -2511
Top Gainers
| Symbol | Change% |
|---|---|
| WORTH | 146.13(20%) |
| GREAVESCOT | 281.83(20%) |
| ELGIRUBCO | 146.84(13%) |
| AGRITECH | 210.05(11%) |
| SARLAPOLY | 123.19(10%) |
Similar stocks
Announcing Stock of the Month!
